Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Svetlana V. Aidagulova"'
Autor:
Stanislav D. Aladev, Dmitry K. Sokolov, Anastasia V. Strokotova, Galina M. Kazanskaya, Alexander M. Volkov, Svetlana V. Aidagulova, Elvira V. Grigorieva
Publikováno v:
Neurology International, Vol 16, Iss 4, Pp 790-803 (2024)
Glucocorticoids are used during glioblastoma treatment to prevent the cerebral edema effect surrounding normal brain tissue. The aim of our study was to investigate the long-term effects of multiple administrations of glucocorticoids onto the glycosy
Externí odkaz:
https://doaj.org/article/57363cfd75b040689044e0763c238642
Autor:
Dmitry K. Sokolov, Oleg B. Shevelev, Anna S. Khotskina, Alexandra Y. Tsidulko, Anastasia V. Strokotova, Galina M. Kazanskaya, Alexander M. Volkov, Evgenii E. Kliver, Svetlana V. Aidagulova, Evgenii L. Zavjalov, Elvira V. Grigorieva
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 12, p 10243 (2023)
Glioblastoma (GB) is an aggressive cancer with a high probability of recurrence, despite active chemoradiotherapy with temozolomide (TMZ) and dexamethasone (DXM). These systemic drugs affect the glycosylated components of brain tissue involved in GB
Externí odkaz:
https://doaj.org/article/8edd6e4f5d6345d8a37cc0a8f9e5d870
Autor:
Alexandra Y. Tsidulko, Oleg B. Shevelev, Anna S. Khotskina, Mariia A. Kolpakova, Anastasia V. Suhovskih, Galina M. Kazanskaya, Alexander M. Volkov, Svetlana V. Aidagulova, Evgenii L. Zavyalov, Elvira V. Grigorieva
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Adjuvant chemotherapy with temozolomide (TMZ) is an intrinsic part of glioblastoma multiforme (GBM) therapy targeted to eliminate residual GBM cells. Despite the intensive treatment, a GBM relapse develops in the majority of cases resulting in poor o
Externí odkaz:
https://doaj.org/article/51ec4338a983464d874d2e3e6aa66255
Autor:
Maxim O. Politko, Alexandra Y. Tsidulko, Oxana A. Pashkovskaya, Konstantin E. Kuper, Anastasia V. Suhovskih, Galina M. Kazanskaya, Lyubov S. Klyushova, Dmitry K. Sokolov, Alexander M. Volkov, Evgenii E. Kliver, Alexander A. Zheravin, Svetlana V. Aidagulova, Elvira V. Grigorieva
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 24, p 13350 (2021)
Intensive adjuvant radiotherapy (RT) is a standard treatment for glioblastoma multiforme (GBM) patients; however, its effect on the normal brain tissue remains unclear. Here, we investigated the short-term effects of multiple irradiation on the cellu
Externí odkaz:
https://doaj.org/article/c0b64f2e63674c5baabfdca94a43b6d2
Autor:
Vladimir I. Konenkov, Alla V. Shevchenko, Viktor F. Prokofiev, Elena G. Koroleva, Yulia S. Timofeeva, Svetlana V. Aidagulova, Igor' O. Marinkin
Publikováno v:
Медицинская иммунология, Vol 0, Iss 0 (2019)
Uterine leiomyomas (LM), or uterine fibroids (UF), are benign tumors of the uterus. Hypertrophic increase in muscle mass in LM is accompanied by the development of appropriate vascular networks, which are regulated by the balance of proangiogenic fac
Externí odkaz:
https://doaj.org/article/88bcf5b0f5d14b83a7a7d0cda2c83b26
Autor:
Anastasia V. Suhovskih, Galina M. Kazanskaya, Alexander M. Volkov, Alexandra Y. Tsidulko, Svetlana V. Aidagulova, Elvira V. Grigorieva
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 4, p 1301 (2020)
Adjuvant chemoradiotherapy is a standard treatment option for glioblastoma multiforme (GBM). Despite intensive care, recurrent tumors developed during the first year are fatal for the patients. Possibly contributing to this effect, among other causes
Externí odkaz:
https://doaj.org/article/504703a690cd4d8eae9196e48a275066
Autor:
Alexandra Y. Tsidulko, Cynthia Bezier, Gabin de La Bourdonnaye, Anastasia V. Suhovskih, Tatiana M. Pankova, Galina M. Kazanskaya, Svetlana V. Aidagulova, Elvira V. Grigorieva
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Temozolomide (TMZ) is a conventional chemotherapy drug for adjuvant treatment of glioblastoma multiforme (GBM), often accompanied by dexamethasone (DXM) to prevent brain oedema and alleviate clinical side effects. Here, we aimed to investigate an abi
Externí odkaz:
https://doaj.org/article/255a8eb34d7740c882894190f5e5dbbe
Autor:
Tatyana S. Taranina, Svetlana V. Aidagulova, Alexander I. Neymark, Yuliya S. Kondratyeva, Andrey A. Yakovlev
Publikováno v:
International Journal of Biomedicine, Vol 3, Iss 3, Pp 170-173 (2013)
The objective of this study was the investigation of the influence of ureaplasmal infection on the development of urethral meatus polyps in women. The article presents the results of the examination of women with chronic cystitis and urethritis over
Externí odkaz:
https://doaj.org/article/3967659c83c14c3e8b6e3323bab66cb2
Autor:
Victor S. Ushakov, Alexandra Y. Tsidulko, Gabin de La Bourdonnaye, Galina M. Kazanskaya, Alexander M. Volkov, Roman S. Kiselev, Vyacheslav V. Kobozev, Diana V. Kostromskaya, Alexey S. Gaytan, Alexei L. Krivoshapkin, Svetlana V. Aidagulova, Elvira V. Grigorieva
Publikováno v:
International Journal of Molecular Sciences, Vol 18, Iss 11, p 2301 (2017)
Heparan sulfate (HS) is an important component of the extracellular matrix and cell surface, which plays a key role in cell–cell and cell–matrix interactions. Functional activity of HS directly depends on its structure, which determined by a comp
Externí odkaz:
https://doaj.org/article/f0af2d231d9649dea85d515fcb0fa0cf
Autor:
Grigorieva, Dmitry K. Sokolov, Oleg B. Shevelev, Anna S. Khotskina, Alexandra Y. Tsidulko, Anastasia V. Strokotova, Galina M. Kazanskaya, Alexander M. Volkov, Evgenii E. Kliver, Svetlana V. Aidagulova, Evgenii L. Zavjalov, Elvira V.
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 12; Pages: 10243
Glioblastoma (GB) is an aggressive cancer with a high probability of recurrence, despite active chemoradiotherapy with temozolomide (TMZ) and dexamethasone (DXM). These systemic drugs affect the glycosylated components of brain tissue involved in GB